SCOPUS 정보 검색 플랫폼

Volumn 85, Issue 4, 2001, Pages 509-517

Factors predicting efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) ± folinic acid in a compassionate-use cohort of 481 5-FU-resistant advanced colorectal cancer patients

(10) Bensmane, M A a Marty, M b De Gramont, A c Brienza, S d Levi F e Ducreux, M f Francois E g Gamelin, E h Bleiberg, H i Cvitkovic, E a,e

a Cvitkovic et Associes Consultants (France)

b SAINT LOUIS HOSPITAL (France)

c HÔPITAL SAINT ANTOINE (France)

d Debioclinic (France)

e HÔPITAL PAUL BROUSSE (France)

f INSTITUT GUSTAVE ROUSSY (France)

g Centre Lacassagne (France)

h CENTRE PAUL PAPIN (France)

i JULES BORDET INSTITUTE (Belgium)

Author keywords

Clinical resistance; Multivariate analysis; Salvage chemotherapy

Indexed keywords

ALKALINE PHOSPHATASE; FLUOROURACIL; FOLINIC ACID; HEMOGLOBIN; OXALIPLATIN;

ADULT; ADVANCED CANCER; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; EUROPE; FEMALE; GENDER; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEX DIFFERENCE; STATISTICAL ANALYSIS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17944376134 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1054/bjoc.2001.1953 Document Type: Article

Times cited : (18)

References (38)

1
- 0026721532
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
- (1992) J Clin Oncol , vol.10 , pp. 896-903

2
- 0032730143
- Multicenter phase II study of bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin regimen (FOLFOX 3/4)
- (1999) J Clin Oncol , vol.17 , pp. 3560-3568
- André, T.¹ Bensmaine, A.² Louvet, C.³ Francois, E.⁴ Lucas, V.⁵ Desseigne, F.⁶ Beerblock, K.⁷ Bouché, O.⁸ Carola, E.⁹ Merrouche, Y.¹⁰ Morvan, F.¹¹ Dupont-André, G.¹² De Gramont, A.¹³

3
- 0344783805
- Phase II trial of oxaliplatin as first line chemotherapy in metastatic colorectal cancer patients
- (1998) J Clin Oncol , vol.16 , pp. 2739-2744
- Bécouarn, Y.¹ Ychou, M.² Ducreux, M.³ Borel, C.⁴ Bertheault-Cvitkovic, F.⁵ Seitz, J.⁶ Nasca, S.⁷ Nguyen, T.⁸ Paillot, B.⁹ Raoul, J.¹⁰ Duffour, J.¹¹ Fandi, A.¹² Dupont-André, G.¹³ Rougier, P.¹⁴

4
- 0035890465
- 2) and alternating irinotecan and oxaliplatin, with oxaliplatin/irinotecan in 5-FU-pretreated metastatic colorectal cancer patients
- in press
- (2001) J Clin Oncol
- Bécouarn, Y.¹ Gamelin, E.² Coudert, B.³ Négrier, S.⁴ Pierga, J.Y.⁵ Raoul, J.L.⁶ Provencal, J.⁷ Rixe, O.⁸ Krisch, C.⁹ Germau, C.¹⁰ Bekradda, M.¹¹ Mignard, D.¹² Mousseau, M.¹³

5
- 0001212709
- Protracted venous 5-fluorouracil infusion and weekly cisplatin in metastatic colorectal cancer
- (1989) Proc Am Soc Clin Oncol , vol.8 , pp. 126
- Behrens, B.C.¹ Sickle-Santanello, B.² Martin, E.³

6
- 10344253782
- Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer
- (1996) J Clin Oncol , vol.14 , pp. 2950-2958
- Bertheault-Cvitkovic, F.¹ Jami, A.² Itzhaki, M.³ Depres-Brummer, P.⁴ Brienza, S.⁵ Adam, R.⁶ Kunstlinger, F.⁷ Bismuth, H.⁸ Misset, J.L.⁹ Lévi, F.¹⁰

7
- 0026580502
- Cancer statistics, 1992
- (1992) CA Cancer J Clin , vol.42 , pp. 19-38
- Boring, C.C.¹ Squires, T.S.² Tong, T.³

8
- 0003667273
- London, England
- (1970) The Analysis of binary data
- Cox, D.R.¹

9
- 0000336139
- Regression models and life-tables
- (1972) J R Stat Soc , vol.34 , pp. 187-220
- Cox, D.R.¹

10
- 0030888321
- Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer
- (1997) Eur J Cancer , vol.33 A , pp. 214-219
- De Gramont, A.¹ Vignoud, J.² Tournigand, C.³ Louvet, C.⁴ André, T.⁵ Varette, C.⁶ Raymond, E.⁷ Moreau, S.⁸ Le Bail, N.⁹ Krulik, M.¹⁰

11
- 0033874892
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
- (2000) J Clin Oncol , vol.18 , pp. 2938-2947
- De Gramont, A.¹ Figer, A.² Seymour, M.³ Homerin, M.⁴ Hmissi, A.⁵ Cassidy, J.⁶ Boni, C.⁷ Cortes-Funes, H.⁸ Cervantes, A.⁹ Freyer, G.¹⁰ Papamichael, D.¹¹ Le Bail, N.¹² Louvet, C.¹³ Hendler, D.¹⁴ De Braud, F.¹⁵ Wilson, C.¹⁶ Morvan, F.¹⁷ Bonetti, A.¹⁸

12
- 0034712536
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
- (2000) Lancet , vol.355 , pp. 1041-1047
- Douillard, J.Y.¹ Cunningham, D.² Roth, A.³ Navarro, M.⁴ James, R.⁵ Karasek, P.⁶ Jandik, P.⁷ Iveson, T.⁸ Carmichael, J.⁹ Alakl, M.¹⁰ Gruia, G.¹¹ Awad, L.¹² Rougier, P.¹³

13
- 0028351435
- Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: Clinical evidence of incomplete cross-resistance
- (1994) Ann Oncol , vol.5 , pp. 291
- Falcone, A.¹ Cianci, C.² Pfanner, E.³ Bertuccelli, I.⁴ Muttini, M.P.⁵ Dargenio, F.⁶ Ricci, S.⁷ Conte, P.F.⁸

14
- 0000723817
- Addition of oxaliplatin (L-OHP®) to chronomodulated (CM) 5-fluorouracil (5-FU) and folinic acid (FA) for reversal of acquired chemoresistance in patients with advanced colorectal cancer (ACC)
- (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 192
- Garufi, C.¹ Brienza, S.² Bensmaine, A.³ Misset, J.L.⁴ Aschelter, A.⁵ Pace, R.⁶ Bertheault-Cvitkovic, F.⁷ Terzoli, E.⁸ Lévi, F.⁹

15
- 0000361204
- Oxaliplatin combined to 5-FU and Folinic Acid (5-FU/FA) as second or third line treatment in patients with advanced colorectal cancer (CRC)
- (1997) Proc Am Soc Clin Oncol , vol.16
- Gerard, B.¹ Bleiberg, H.² Michel, J.³ Finet, C.⁴ Recloux, P.⁵ Diana, D.⁶ Dufrane, J.P.⁷ Vandaele, D.⁸ Hendlisz, A.⁹ Confente, C.¹⁰ Malarme, M.¹¹ Michaux, D.¹² Brienza, S.¹³

16
- 0031747923
- Oxaliplatin combined to 5-fluorouracil and folinic acid: An effective salvage therapy in patients with advanced colorectal cancer
- (1998) Anti-Cancer Drugs , vol.9 , pp. 301-305
- Gerard, B.¹ Bleiberg, H.² Vandaele, D.³ Gil, T.⁴ Hendlisz, A.⁵ Di Leo, A.⁶ Fernez, B.⁷ Brienza, S.⁸

17
- 0033989203
- Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
- (2000) J Clin Oncol , vol.18 , pp. 136-147
- Giacchetti, S.¹ Perpoint, B.² Zidani, R.³ Le Bail, N.⁴ Faggiuolo, R.⁵ Focan, C.⁶ Chollet, P.⁷ Llory, J.F.⁸ Letourneau, Y.⁹ Coudert, B.¹⁰ Bertheault-Cvitkovic, F.¹¹ Larregain-Fournier, D.¹² Le Rol, A.¹³ Walter, S.¹⁴ Adam, R.¹⁵ Misset, J.L.¹⁶ Lévi, F.¹⁷

18
- 0033637555
- Dose escalation of CPT-11 in combination with oxaliplatin using an every two weeks schedule: A phase I study in advanced gastrointestinal cancer patients
- (2000) Ann Oncol , vol.11 , pp. 1463-1470
- Goldwasser, F.¹ Gross-Goupil, M.² Tigaud, J.M.³ Di Palma, M.⁴ Marceau-Suissa, J.⁵ Wasserman, E.⁶ Yovine, A.⁷ Misset, J.L.⁸ Cvitkovic, E.⁹

19
- 0028060451
- The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer
- (1994) Br J Cancer , vol.70 , pp. 559-563
- Graf, W.¹ Pahlman, L.² Bergström, R.³ Glimelius, B.⁴

20
- 0029016021
- Royal mardsen phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer
- (1995) J Clin Oncol , vol.13 , pp. 1297-1302
- Hill, M.¹ Norman, A.² Cunningham, D.³ Findlay, M.⁴ Nicolson, V.⁵ Hill, A.⁶ Iveson, A.⁷ Evans, C.⁸ Joffe, J.⁹ Nicolson, M.¹⁰

21
- 0002634070
- Chemotherapy with cisplatinum (CDDP) and 5FU in metastatic colorectal cancer
- (1988) Proc Am Soc Clin Oncol , vol.7 , pp. 114
- Iyer, P.R.¹ Moran, E.M.² Kaneshiro, C.A.³ Ottenheimer, E.J.⁴ El Sayad, N.I.⁵ Blitzer, J.B.⁶ Charter, R.A.⁷

22
- 0001484744
- Low-dose protracted continuous 5-fluorouracil infusion in solid tumors
- (1994) Journal of Infusional Chemotherapy , vol.4 , pp. 135-139
- Izzo, J.¹ Fandi, A.² Villalobos, W.³ Azli, N.⁴ Bachouchi, M.⁵ Levin, F.M.⁶ Benahmed, M.⁷ Armand, J.⁸ Rougier, P.⁹ Cvitkovic, E.¹⁰

23
- 0026512446
- A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump
- (1992) Cancer , vol.69 , pp. 893-900
- Lévi, F.¹ Misset, J.L.² Brienza, S.³ Adam, R.⁴ Metzger, G.⁵ Itzhaki, M.⁶ Caussanel, J.P.⁷ Kunstlinger, F.⁸ Lecouturier, S.⁹ Descorps-Declere, A.¹⁰ Jasmin, C.¹¹ Bismuth, H.¹² Reinberg, A.¹³

24
- 0027310715
- Oxaliplatin activity against metastatic colorectal cancer: A phase II study of 5-day continuous venous infusion at circadian-rhythm modulated rate
- (1993) Eur J Cancer , vol.29 A , pp. 1280-1284
- Lévi, F.¹ Perpoint, B.² Garufi, C.³ Focan, C.⁴ Chollet, P.⁵ Depres-Brummer, P.⁶ Zidani, R.⁷ Brienza, S.⁸ Itzhaki, M.⁹ Iacobelli, S.¹⁰ Kunstlinger, F.¹¹ Gastiaburu, C.¹² Misset, J.L.¹³

25
- 0024836479
- Low-dose continuous infusion 5-fluorouracil and cisplatin: Phase II evaluation in advanced colorectal carcinoma
- (1989) J Clin Oncol , vol.12 , pp. 486-490
- LoRusso, P.¹ Pazdur, R.² Redman, S.G.³

26
- 0012797224
- Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines
- (1996) Ann Oncol , vol.7 , pp. 95-98
- Machover, D.¹ Diaz-Rubio, E.² De Gramont, A.³ Schilf, A.⁴ Gastiaburu, C.⁵ Brienza, S.⁶ Itzhaki, M.⁷ Metzger, G.⁸ N'Daw, D.⁹ Vignoud, J.¹⁰ Abad, A.¹¹ Francois, E.¹² Gamelin, E.¹³ Marty, M.¹⁴ Sastre, J.¹⁵ Seitz, J.¹⁶ Ychou, M.¹⁷

27
- 0002958698
- Oxaliplatin (LOHP) and 5-fluorouracil (5-FU) synergism in advanced colorectal cancer patients (ACRC)
- (1997) Eur J Cancer , vol.33
- Meyer, V.¹ Delva, R.² Gamelin, E.³ Lamezec, B.⁴ Maillart, P.⁵ Danquechin-Dorval, E.⁶ Lortholary, A.⁷ Boisdron-Celle, M.⁸ Maigre, M.⁹ Brienza, S.¹⁰ Cvitkovic, E.¹¹ Larra, F.¹²

28
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, A.⁴

29
- 0024555598
- Combination chemotherapy of cisplatin and 5-fluorouracil for advanced colorectal adenocarcinoma
- (1989) Cancer Chemother Pharmacol , vol.23 , pp. 57-60
- Petrelli, N.J.¹ Madejewicz, S.² Rustum, Y.³

30
- 0031741679
- Oxaliplatin: A review of preclinical and clinical studies
- (1998) Ann Oncol , vol.9 , pp. 1053-1071
- Raymond, E.¹ Chaney, S.² Taamma, A.³ Cvitkovic, E.⁴

31
- 0031864830
- Oxaliplatin: Mechanism of action and antineoplastic activity
- (1998) Semin Oncol , vol.25 , pp. 4-12
- Raymond, E.¹ Faivre, S.² Woynarowski, J.³ Chaney, S.⁴

32
- 0032585197
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1407-1412
- Rougier, P.¹ Van Cutsem, E.² Bajetta, E.³ Niederle, N.⁴ Possinger, K.⁵ Labianca, R.⁶ Navarro, M.⁷ Morant, R.⁸ Bleiberg, H.⁹ Wils, J.¹⁰ Awad, L.¹¹ Herait, P.¹² Jacques, C.¹³

33
- 0034727063
- Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
- Irinotecan Study Group
- (2000) N Engl J Med , vol.343 , pp. 905-914
- Saltz, L.¹ Cox, J.V.² Blanke, C.³ Rosen, L.S.⁴ Fehrenbacher, L.⁵ Moore, M.⁶ Maroun, J.A.⁷ Ackland, S.⁸ Locker, P.⁹ Pirotta, N.¹⁰ Elfring, G.¹¹ Miller, L.L.¹²

34
- 9844249674
- Five-Day continuous infusion of 5-fluorouracil and pulsed folinic acid in patients with metastatic colorectal carcinoma: An effective second-line regimen
- (1997) Ann Oncol , vol.8 , pp. 1163-1165
- Streit, M.¹ Jaehde, U.² Stremetzne, S.³ Ridwelski, K.⁴ Kerz, H.⁵ Strohbach, F.⁶ Hohenberger, P.⁷ Zwiebel, F.M.⁸ Hebart, H.⁹ Bothig, R.¹⁰ Kairies, M.¹¹ Zillig, D.¹² Schuchmann, S.¹³ Warnecke, S.¹⁴ Thiel, E.¹⁵ Kreuser, E.¹⁶

35
- 0003226922
- FOLFIRI followed by FOLFOX versus FOLFOX followed by FOLFIRI in Metastatic Colorectal Cancer (MCRC): Final results of a Phase III study
- (2001) Proc Am Soc Clin Oncol , vol.20
- Tournigand, C.¹ Louvet, C.² Quinaux, E.³ Andre, T.⁴ Lledo, G.⁵ Flesch, M.⁶ Ganem, G.⁷ Landi, B.⁸ Colin, P.⁹ Denet, C.¹⁰ Mery-Mignard, D.¹¹ Risse, M.-L.¹² Buyse, M.¹³ De Gramont, A.¹⁴

36
- 0021179529
- Influence of measurement error on assessment of response to anticancer chemotherapy: Proposal for new criteria of tumor response
- (1984) J Clin Oncol , vol.2 , pp. 1040
- Warr, D.¹ McKinney, S.² Tannock, I.F.³

37
- 0033002906
- Combination of oxaliplatin plus irinotecan in patients with gastrointestinal tumors: Results of two independent phase I studies with pharmacokinetics
- (1999) J Clin Oncol , vol.17 , pp. 1751-1759
- Wasserman, E.¹ Cuvier, C.² Lokiec, F.³ Goldwasser, F.⁴ Kalla, S.⁵ Méry-Mignard, D.⁶ Ould Kaci, M.⁷ Bensmaine, A.⁸ Dupont-André, G.⁹ Mahjoubi, M.¹⁰ Marty, M.¹¹ Misset, J.L.¹² Cvitkovic, E.¹³

38
- 0026328021
- A phase II study of 5-fluorouracil plus cisplatin for metastatic colorectal adenocarcinoma: A south-west oncology group (SWOG) study
- (1991) Invest New Drugs , vol.9 , pp. 345-347
- Whitehead, R.P.¹ Fleming, T.² Macdonald, J.S.³ Ahmann, F.R.⁴ Garewal, H.⁵ Kuebler, J.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.